Transcode Therapeutics, Inc. · NASDAQ:RNAZ

CK Life Sciences Int'l., (Holdings) Inc. reported a 83.90% stake in Transcode Therapeutics, Inc. (Schedule 13D/A)

Event Aug 3, 2026 · Filed Aug 3, 2026

CK Life Sciences Int'l., (Holdings) Inc. reported a 83.90% stake in Transcode Therapeutics, Inc., 14,134,481 shares, with active intent on Aug 3, 2026. Filed Aug 3, 2026 (Schedule 13D/A).

Stake
83.90%
Shares
14,134,481
Intent
Active
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
DEFJ, LLC83.90%14,134,481
CK Life Sciences Int'l., (Holdings) Inc.83.90%14,134,481

Source

View original at SEC

Related